Publications by authors named "Millind Javle"
Article Synopsis
- The study focused on KRAS mutations to assess the importance of circulating tumor DNA (ctDNA) in advanced pancreatic cancer patients undergoing chemotherapy.
- Blood samples were collected from 14 patients before and during treatment, using a specialized PCR method to detect KRAS mutations as a marker for ctDNA.
- The results indicated that higher pre-treatment ctDNA levels were linked to worse disease outcomes, suggesting ctDNA could help monitor treatment effectiveness and disease progression in pancreatic cancer.
